Concepedia

Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern

Renato Sathler-Avelar, Danielle Marquete Vitelli-Avelar, Rodrigo Lima Massara, Marta de Lana, João Carlos Pinto Dias, Andréa Teixeira‐Carvalho, Silvana Maria Elói-Santos, Olindo Assis Martins‐Filho

Microbes and Infection · 2007 · 56 citations · 19 references

DOIFull text

Open access

Concepts

References

19

The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF

Kai-Uwe Belge, Farshid Dayyani, Alexia Horelt et al. · The Journal of Immunology · 2002 · 876 citations · Full text

, , +13

Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection

Ana Lúcia Sampaio Sgambatti de Andrade, Fábio Zicker, Renato Maurício de Oliveira et al. · The Lancet · 1996 · 516 citations

, , +10

Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.

Sérgio Sosa Estani, E L Segura, A. M. RUIZ et al. · American Journal of Tropical Medicine and Hygiene · 1998 · 425 citations · Full text

, , +17

Treatment of chronic Chagas' disease with benznidazole: Clinical and serologic evolution of patients with long-term follow-up

Rodolfo Viotti, Carlos Vigliano, HECTOR A. ARMENTI et al. · American Heart Journal · 1994 · 325 citations

, , +6

Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune Response

Juliana de Assis Silva Gomes, Lilian M. G. Bahia‐Oliveira, Manoel Otávio da Costa Rocha et al. · Infection and Immunity · 2003 · 323 citations · Full text

, , +15